Molecular insight into 2-phosphoglycolate activation of the phosphatase activity of bisphosphoglycerate mutase
- PMID: 35362470
- PMCID: PMC8972806
- DOI: 10.1107/S2059798322001802
Molecular insight into 2-phosphoglycolate activation of the phosphatase activity of bisphosphoglycerate mutase
Abstract
Bisphosphoglycerate mutase (BPGM) is an erythrocyte-specific multifunctional enzyme that is responsible for the regulation of 2,3-bisphosphoglycerate (2,3-BPG) in red blood cells through its synthase and phosphatase activities; the latter enzymatic function is stimulated by the endogenous activator 2-phosphoglycolate (2-PG). 2,3-BPG is a natural allosteric effector of hemoglobin (Hb) that is responsible for decreasing the affinity of Hb for oxygen to facilitate tissue oxygenation. Here, crystal structures of BPGM with 2-PG in the presence and absence of 3-phosphoglycerate are reported at 2.25 and 2.48 Å resolution, respectively. Structure analysis revealed a new binding site for 2-PG at the dimer interface for the first time, in addition to the expected active-site binding. Also, conformational non-equivalence of the two active sites was observed as one of the sites was found in an open conformation, with the residues at the active-site entrance, including Arg100, Arg116 and Arg117, and the C-terminus disordered. The kinetic result is consistent with the binding of 2-PG to an allosteric or noncatalytic site as well as the active site. This study paves the way for the rational targeting of BPGM for therapeutic purposes, especially for the treatment of sickle cell disease.
Keywords: 2,3-bisphosphoglycerate; 2-phosphoglycolate; X-ray crystallography; bisphosphoglycerate mutase; kinetics; phosphatases; synthases.
open access.
Figures




Similar articles
-
Critical role of human bisphosphoglycerate mutase Cys22 in the phosphatase activator-binding site.J Biol Chem. 1997 May 30;272(22):14045-50. doi: 10.1074/jbc.272.22.14045. J Biol Chem. 1997. PMID: 9162026
-
Hydrogen Sulfide Is a Regulator of Hemoglobin Oxygen-Carrying Capacity via Controlling 2,3-BPG Production in Erythrocytes.Oxid Med Cell Longev. 2021 Feb 13;2021:8877691. doi: 10.1155/2021/8877691. eCollection 2021. Oxid Med Cell Longev. 2021. Retraction in: Oxid Med Cell Longev. 2025 Aug 13;2025:9892050. doi: 10.1155/omcl/9892050. PMID: 33628390 Free PMC article. Retracted.
-
New procedures to measure synthase and phosphatase activities of bisphosphoglycerate mutase. Interest for development of therapeutic drugs.C R Acad Sci III. 1997 Jan;320(1):27-33. doi: 10.1016/s0764-4469(99)80083-3. C R Acad Sci III. 1997. PMID: 9099261
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19. Eur J Cancer. 2007. PMID: 17182241
Cited by
-
Characterization of the Escherichia coli pyridoxal 5'-phosphate homeostasis protein (YggS): Role of lysine residues in PLP binding and protein stability.Protein Sci. 2022 Nov;31(11):e4471. doi: 10.1002/pro.4471. Protein Sci. 2022. PMID: 36218140 Free PMC article.
-
Functional and structural properties of pyridoxal reductase (PdxI) from Escherichia coli: a pivotal enzyme in the vitamin B6 salvage pathway.FEBS J. 2023 Dec;290(23):5628-5651. doi: 10.1111/febs.16962. Epub 2023 Oct 2. FEBS J. 2023. PMID: 37734924 Free PMC article.
-
Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities.Int J Mol Sci. 2022 Jul 4;23(13):7448. doi: 10.3390/ijms23137448. Int J Mol Sci. 2022. PMID: 35806451 Free PMC article. Review.
-
Efficacy of Poloxamer 188 in Experimental Myelosuppression Model Induced by Carboplatin in CBA Mice.Int J Mol Sci. 2025 Jul 23;26(15):7081. doi: 10.3390/ijms26157081. Int J Mol Sci. 2025. PMID: 40806214 Free PMC article.
References
-
- Benesch, R. & Benesch, R. E. (1967). Biochem. Biophys. Res. Commun. 26, 162–167. - PubMed
-
- Benesch, R. & Benesch, R. E. (1969). Nature, 221, 618–622. - PubMed
-
- Bunn, H. F. (1997). N. Engl. J. Med. 337, 762–769. - PubMed
-
- Bunn, H. F. & Forget, B. G. (1986). Hemoglobin: Molecular, Genetic and Clinical Aspects. Philadelphia: W. B. Saunders.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous